Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency

NCT00005098 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2005-06-24

No results posted yet for this study

Summary

OBJECTIVES:

I. Establish cell lines from patients with alpha 1-antitrypsin deficiency in order to examine genetic traits that predispose to liver injury.

Conditions

Sponsors & Collaborators

  • University of Pittsburgh

    collaborator OTHER
  • National Center for Research Resources (NCRR)

    lead NIH

Principal Investigators

  • David H. Perlmutter · University of Pittsburgh

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005098 on ClinicalTrials.gov